Introduction: Pathogenic variants of the GATA2 transcription factor are one of the most common predisposing mutations of familial myeloid malignancies, including acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS). This evidence concerns the gene GATA2 and myelodysplastic syndrome.